CAS: 78536-37-5 - (1alpha,5beta,7alpha,9beta,10alpha,12alpha,14S)-1,7,12,14-tetrahydroxykaur-16-en-15-one
Formula:C20H30O5
InChI:InChI=1S/C20H30O5/c1-9-15-10(21)7-12-19(4)11(18(2,3)6-5-13(19)22)8-14(23)20(12,16(9)24)17(15)25/h10-15,17,21-23,25H,1,5-8H2,2-4H3/t10-,11+,12-,13-,14+,15+,17+,19+,20-/m0/s1
InChI key:InChIKey=NFENNPKUXFGPST-WEMBNSTNSA-N
SMILES:O=C1C(=C)C2C(O)CC3C1(C(O)CC4C(C)(C)CCC(O)C43C)C2O
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | excisanin A REF: AN-AG00G74GCAS: 78536-37-5 | 98.0% | To inquire | Tue 21 May 24 |
 | Excisanin A REF: TM-TN4046CAS: 78536-37-5 | 98% | To inquire | Tue 21 May 24 |
 | Excisanin A REF: BP-SBP03550CAS: 78536-37-5 | 95%~99% | To inquire | Wed 22 May 24 |
 | Excisanin A REF: 3D-DDA53637CAS: 78536-37-5 | Min. 95% | To inquire | Tue 02 Jul 24 |
Excisanin A
CAS:78536-37-5
ExcisaninA may be a potent inhibitor of AKT signaling pathway in tumor cells, it can …
Formula:
C20H30O5
Purity:
98%
Color and Shape:
Solid
Molecular weight:
350.45
- G-protein Coupled Receptors and 7-TM Receptors
- Inhibitors
- Angiogenesis
- FAK
- See more categories
- Apoptosis
- Caspase
- Chromatin/Epigenetics
- DNA Damage/DNA Repair
- Prostaglandin Receptor
- Immunology and Inflammation
- NF-κB
- JNK
- MAPK
- Proteases/Proteasome
- Stem Cell and Derivatives
- Wnt/beta-catenin
- Stem Cells
- Tyrosine Kinase/Adaptors
- GPCR/G-Protein
- PI3K/Akt/mTOR Signaling
- gsk-3
- PI3K
- Cytoskeletal Signaling
- Mmp and Impurities
Ref: TM-TN4046
| 1mg | To inquire | |
| 5mg | To inquire |
Estimated delivery in United States, on Tuesday 21 May 2024
Ref: BP-SBP03550
| Undefined size | To inquire |
Estimated delivery in United States, on Wednesday 22 May 2024
Excisanin A
CAS:78536-37-5
Excisanin A is a natural drug that has been found in the human liver and …
Formula:
C20H30O5
Purity:
Min. 95%
Molecular weight:
350.4 g/mol
Ref: 3D-DDA53637
| 1mg | To inquire | |
| 5mg | To inquire | |
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire |
Estimated delivery in United States, on Tuesday 2 Jul 2024
